PF4 and COVID-19: As in heparin treatment where non-pathogenic anti-PF4 antibodies are commonly found31 non-activating anti-PF4 antibodies are more frequently found following COVID-19 vaccinations (both mRNA- and adenovirus-based vaccines)30.